EDAP
Edap Tms S.a. NASDAQ Listed Aug 1, 1997$3.60
After hrs
$3.63
+0.97%
Mkt Cap $134.7M
52w Low $1.21
62.1% of range
52w High $5.05
50d MA $3.72
200d MA $2.91
P/E (TTM)
-4.5x
EV/EBITDA
-6.1x
P/B
6.7x
Debt/Equity
1.4x
ROE
-150.7%
P/FCF
-6.5x
RSI (14)
—
ATR (14)
—
Beta
-0.08
50d MA
$3.72
200d MA
$2.91
Avg Volume
51.9K
About
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | AMC | -0.16 | -0.25 | -56.2% | 3.71 | +5.9% | +1.6% | +0.5% | -2.4% | +0.3% | -4.9% | — |
| Nov 6, 2025 | AMC | -0.26 | -0.15 | +42.3% | 1.99 | +3.5% | +1.5% | +2.0% | +1.5% | +1.5% | +6.5% | — |
| Aug 28, 2025 | AMC | -0.18 | -0.17 | +5.6% | 1.82 | +3.8% | +24.2% | +51.6% | +51.1% | +38.5% | +38.5% | — |
| May 15, 2025 | AMC | -0.16 | -0.20 | -25.0% | 1.76 | -0.6% | +0.0% | +5.7% | +8.0% | -1.1% | +2.3% | — |
| Mar 27, 2025 | AMC | -0.11 | -0.05 | +54.5% | 2.22 | +3.2% | -3.2% | -11.7% | -11.7% | -15.8% | -14.0% | — |
| Nov 7, 2024 | AMC | -0.16 | -0.19 | -18.8% | 2.73 | -2.9% | -5.9% | -7.0% | -3.3% | -3.7% | -7.7% | — |
| Aug 28, 2024 | AMC | -0.14 | -0.18 | -28.6% | 2.99 | +5.0% | +9.0% | +21.1% | +16.7% | +7.4% | +5.0% | — |
| May 16, 2024 | AMC | -0.10 | -0.13 | -30.0% | 6.89 | +0.3% | -2.6% | -9.6% | -12.8% | -12.6% | -14.2% | — |
| Mar 27, 2024 | AMC | -0.05 | -0.15 | -229.0% | 7.10 | +0.0% | +3.5% | +6.5% | +6.6% | +9.4% | +11.5% | — |
| Nov 9, 2023 | AMC | -0.11 | -0.12 | -9.1% | 5.26 | -1.1% | -4.6% | -19.6% | -21.1% | -6.3% | -10.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.37 | $3.56 | +5.6% | -0.3% | -2.1% | -1.2% | +0.0% | +4.5% |
| Apr 4 | Jefferies | Downgrade | Buy → Hold | — | $1.91 | $1.89 | -1.0% | -15.7% | -24.1% | -23.6% | -20.4% | -24.1% |
| Mar 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.22 | $2.29 | +3.2% | -3.2% | -11.7% | -11.7% | -15.8% | -14.0% |
| Mar 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.22 | $2.29 | +3.2% | -3.2% | -11.7% | -11.7% | -15.8% | -14.0% |
| Aug 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.99 | $3.14 | +5.0% | +9.0% | +21.1% | +16.7% | +7.4% | +5.0% |
| Jul 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.10 | $4.90 | -3.9% | -2.5% | -9.4% | -6.5% | -8.2% | -8.8% |
| May 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.89 | $6.91 | +0.3% | -2.6% | -9.6% | -12.8% | -12.6% | -14.2% |
| Apr 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.35 | $7.58 | +3.1% | +2.9% | +3.0% | +5.7% | +7.8% | +10.9% |
| Nov 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.26 | $5.20 | -1.1% | -4.6% | -19.6% | -21.1% | -6.3% | -10.6% |
| Aug 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.08 | $8.10 | +0.2% | +0.7% | -1.4% | +0.1% | -0.1% | -0.4% |
Recent Filings
Data updated apr 26, 2026 10:24am
· Source: massive.com